Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
Completed · Phase 4
Conditions studied: Glaucoma
In brief
Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.
Key facts
- Study ID
- NCT00444665
- Run by
- Alcon Research
- People needed
- 750
- Starts
- 2007-05-01
- Expected to finish
- 2007-08-01
- Last updated by the study team
- 2016-11-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adults with a clinical diagnosis of ocular hypertension, or primary open-angle, pigment dispersion or exfoliation glaucoma in at least one eye (study eye)
You may not qualify if…
- Age
Where it is running
- Fridley — Fridley, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.